Literature DB >> 15797465

Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.

Pavel L Katsel1, Kenneth L Davis, Vahram Haroutunian.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15797465     DOI： 10.1016/S0074-7742(05)63003-6

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN： 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  19 in total

Review 1.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

Review 2.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

3.  Differential microarray analysis of Drosophila mushroom body transcripts using chemical ablation.

Authors:  Masatomo Kobayashi; Lydia Michaut; Ayako Ino; Ken Honjo; Taiki Nakajima; Yasushi Maruyama; Hiroaki Mochizuki; Mai Ando; Indrayani Ghangrekar; Kuniaki Takahashi; Kaoru Saigo; Ryu Ueda; Walter J Gehring; Katsuo Furukubo-Tokunaga
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

4.  Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.

Authors:  C Conejero-Goldberg; T M Hyde; S Chen; U Dreses-Werringloer; M M Herman; J E Kleinman; P Davies; T E Goldberg
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

5.  Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Melissa J Alldred; Shaoli Che
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

Review 6.  Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.

Authors:  Moussa B H Youdim; Tamar Amit; Orit Bar-Am; Orly Weinreb; Mara Yogev-Falach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

7.  Gene expression reveals overlap between normal aging and Alzheimer's disease genes.

Authors:  Dimitrios Avramopoulos; Megan Szymanski; Ruihua Wang; Susan Bassett
Journal:  Neurobiol Aging       Date:  2010-06-08       Impact factor: 4.673

8.  Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Authors:  J D Buxbaum; L Georgieva; J J Young; C Plescia; Y Kajiwara; Y Jiang; V Moskvina; N Norton; T Peirce; H Williams; N J Craddock; L Carroll; G Corfas; K L Davis; M J Owen; S Harroch; T Sakurai; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2007-04-17       Impact factor: 15.992

Review 9.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 10.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.